Cargando…
A Functional Human-on-a-Chip Autoimmune Disease Model of Myasthenia Gravis for Development of Therapeutics
Myasthenia gravis (MG) is a chronic and progressive neuromuscular disease where autoantibodies target essential proteins such as the nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction (NMJ) causing muscle fatigue and weakness. Autoantibodies directed against nAChRs are proposed t...
Autores principales: | Smith, Virginia M., Nguyen, Huan, Rumsey, John W., Long, Christopher J., Shuler, Michael L., Hickman, James J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645836/ https://www.ncbi.nlm.nih.gov/pubmed/34881241 http://dx.doi.org/10.3389/fcell.2021.745897 |
Ejemplares similares
-
Autoimmune Thyroiditis and Myasthenia Gravis
por: Lopomo, Angela, et al.
Publicado: (2017) -
Inflammation and autoimmune myasthenia gravis
por: Huda, Ruksana
Publicado: (2023) -
New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis
por: Behin, Anthony, et al.
Publicado: (2018) -
Editorial: Advances in Autoimmune Myasthenia Gravis
por: Punga, Anna Rostedt, et al.
Publicado: (2020) -
Structural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications
por: Noridomi, Kaori, et al.
Publicado: (2017)